Empagliflozin/linagliptin Interactions
There are 468 drugs known to interact with empagliflozin/linagliptin, along with 4 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 3 are major, 464 are moderate, and 1 is minor.
- View all 468 medications that may interact with empagliflozin/linagliptin
- View empagliflozin/linagliptin alcohol/food interactions (2)
- View empagliflozin/linagliptin disease interactions (4)
Most frequently checked interactions
View interaction reports for empagliflozin / linagliptin and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Aciphex (rabeprazole)
- Adenoscan (adenosine)
- Aldactone (spironolactone)
- Allegra (fexofenadine)
- Anestacon (lidocaine topical)
- Apriso (mesalamine)
- Aranesp (darbepoetin alfa)
- Arcet (acetaminophen / butalbital / caffeine)
- Asacol (mesalamine)
- Aspirin Low Strength (aspirin)
- Biaxin (clarithromycin)
- Buproban (bupropion)
- Carafate (sucralfate)
- Celebrex (celecoxib)
- CellCept (mycophenolate mofetil)
- Chelated Magnesium (magnesium amino acids chelate)
- Cialis (tadalafil)
- Cimzia (certolizumab)
- Climara (estradiol)
- Coenzyme Q10 (ubiquinone)
- Colazal (balsalazide)
- Glucophage (metformin)
- Lipitor (atorvastatin)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Paracetamol (acetaminophen)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B1 (thiamine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Empagliflozin/linagliptin alcohol/food interactions
There are 2 alcohol/food interactions with empagliflozin / linagliptin.
Empagliflozin/linagliptin disease interactions
There are 4 disease interactions with empagliflozin / linagliptin which include:
Report options
QR code containing a link to this page
More about empagliflozin / linagliptin
- empagliflozin/linagliptin consumer information
- Compare alternatives
- Reviews (23)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidiabetic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
